Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6

被引:76
|
作者
Laman, H
Funes, JM
Ye, HT
Henderson, S
Galinanes-Garcia, L
Hara, E
Knowles, P
McDonald, N
Boshoff, C
机构
[1] UCL, Wolfson Inst Biomed Res, Canc Res UK, Viral Oncol Grp, London, England
[2] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1QP, England
[3] Guangxi Med Univ, Dept Pathol, Guangxi, Peoples R China
[4] Univ Tokushima, Inst Genome Res, Div Prot Informat, Tokushima 770, Japan
[5] London Res Inst, Canc Res UK, Struct Biol Lab, London, England
[6] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England
来源
EMBO JOURNAL | 2005年 / 24卷 / 17期
关键词
cell cycle; cdk6; D cyclin; Fbxo7; transformation;
D O I
10.1038/sj.emboj.7600775
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D cyclins (D1, D2 and D3) and their catalytic subunits (cyclin-dependent kinases cdk4 and cdk6) have a facilitating, but nonessential, role in cell cycle entry. Tissue-specific functions for D-type cyclins and cdks have been reported; however, the biochemical properties of these kinases are indistinguishable. We report that an F box protein, Fbxo7, interacted with cellular and viral D cyclins and distinguished among the cdks that bind D-type cyclins, specifically binding cdk6, in vitro and in vivo. Fbxo7 specifically regulated D cyclin/cdk6 complexes: Fbxo7 knockdown decreased cdk6 association with cyclin and its overexpression increased D cyclin/cdk6 activity and E2F activity. Fbxo7 interacted with p27, but its enhancement of cyclin D/cdk6 activity was p21/p27 independent. Fbxo7 overexpression transformed murine fibroblasts, rendering them tumorigenic in athymic nude mice. Transformed phenotypes were dependent on cdk6, as knockdown of cdk6 reversed them. Fbxo7 was highly expressed in epithelial tumors, but not in normal tissues, suggesting that it may have a proto-oncogenic role in human cancers.
引用
收藏
页码:3104 / 3116
页数:13
相关论文
共 50 条
  • [41] HNRNPA2B1 as a trigger of RNA switch modulates the miRNA-mediated regulation of CDK6
    Yin, Menghui
    Cheng, Meidie
    Liu, Chengli
    Wu, Keli
    Xiong, Wei
    Fang, Ji
    Li, Yinxiong
    Zhang, Biliang
    ISCIENCE, 2021, 24 (11)
  • [42] Hepatocyte growth factor releases mink epithelial cells from transforming growth factor β1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity
    Tsubari, M
    Taipale, J
    Tiihonen, E
    Keski-Oja, J
    Laiho, M
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (05) : 3654 - 3663
  • [43] Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma
    Desai, Shraddha R.
    Pillai, Prajit P.
    Patel, Rekha S.
    McCray, Andrea N.
    Win-Piazza, Hla Y.
    Acevedo-Duncan, Mildred E.
    CARCINOGENESIS, 2012, 33 (01) : 10 - 19
  • [44] A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity
    Nataraj, Sarah E.
    Blain, Stacy W.
    CELL CYCLE, 2021, 20 (08) : 808 - 818
  • [45] CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component
    Xu, Guiyan
    Li, Jian Yi
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (03) : 445 - 452
  • [46] CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component
    Guiyan Xu
    Jian Yi Li
    Journal of Neuro-Oncology, 2018, 136 : 445 - 452
  • [47] Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27Kip1
    Kwon, TK
    Park, JW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (01) : 106 - 111
  • [48] miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting
    Colamaio, Marianna
    Borbone, Eleonora
    Russo, Lucia
    Bianco, Mimma
    Federico, Antonella
    Califano, Daniela
    Chiappetta, Gennaro
    Pallante, Pierlorenzo
    Troncone, Giancarlo
    Battista, Sabrina
    Fusco, Alfredo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (12): : E1915 - E1924
  • [49] Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2
    Ishimi, Y
    Komamura-Kohno, Y
    You, ZY
    Omori, A
    Kitagawa, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) : 16235 - 16241
  • [50] RUNX1/AML1 is phosphorylated at both its N- and C-terminus by cdk6/cyclin D3 or cdk1/cyclin B.
    Fried, FB
    Friedman, AD
    BLOOD, 2005, 106 (11) : 394A - 394A